cardiac conduction system
Recently Published Documents


TOTAL DOCUMENTS

431
(FIVE YEARS 59)

H-INDEX

50
(FIVE YEARS 3)

2022 ◽  
pp. 1-4
Author(s):  
Pierre Loap ◽  
Alfredo Mirandola ◽  
Ludovic De Marzi ◽  
Viviana Vitolo ◽  
Amelia Barcellini ◽  
...  

2022 ◽  
Author(s):  
Rodrigue Fonkou ◽  
Patrick Louodop ◽  
Pierre Kisito Talla

Abstract The heart rhythm is one of the most interesting aspects of the dynamic behavior of biological systems. Understanding heart rhythms is essential in the dynamic analysis of the heart. Each type of dynamic behaviour can describe normal or pathological physiology. The heart is made up of nodes ranging from SA node (natural pacemaker) to Purkinje fibers. The electric current originates in the sinus node and travels through the heart until it reaches the Purkinje fibers, causing after its passage through each of the nodes a heartbeat thus constituting the electrocardiogram (ECG). Since the origin of the electric current is the sinus node, in this article we study numerically and experimentally by microcontroller the influence of the sinus node on the propagation of electric current through the heart. A study of the sinus node in its autonomous state shows us that in their coupled state, the nodes of the heart qualitatively reproduce the time series of the action potential of this latter, which leads to the recording of the ECG. A study when the sinus node is subjected to periodic pulsed excitation E 1(t) = kP(t), assumed to come from blood pressure, with P(t) the blood pressure, shows that for some selected frequencies, it is found that the nodes of the heart and the ECG exhibit responses having the same shape and the same frequencies as those of the pulsatile blood pressure. This suggests the possibility of using such a conversion and excitation mechanism to replicate the functioning of cardiac conduction system. The chaotic analysis of the sinus node subjected to a sinusoidal type disturbance (E 0sin(ωt)) is also presented, it shows that in its chaotic state, the nodes of the heart, as well as the ECG, provide very high frequency signals. This requires the control of the sinus node (natural pacemaker) in such a situation


2021 ◽  
Vol 13 (4) ◽  
pp. 569-584
Author(s):  
Roshan Karki ◽  
Anvi Raina ◽  
Fatima M. Ezzeddine ◽  
Melanie C. Bois ◽  
Samuel J. Asirvatham

2021 ◽  
Vol 13 (4) ◽  
pp. i
Author(s):  
Eric N. Prystowsky ◽  
Benzy J. Padanilam

2021 ◽  
Vol 13 (4) ◽  
pp. xiii
Author(s):  
Ranjan K. Thakur ◽  
Andrea Natale

PLoS ONE ◽  
2021 ◽  
Vol 16 (11) ◽  
pp. e0259123
Author(s):  
Uwajachukwumma A. Uzomah ◽  
Guy Rozen ◽  
Seyed Mohammadreza Hosseini ◽  
Ayman Shaqdan ◽  
Pablo A. Ledesma ◽  
...  

Background Lyme carditis, defined as direct infection of cardiac tissue by Borrelia bacteria, affects up to 10% of patients with Lyme disease. The most frequently reported clinical manifestation of Lyme carditis is cardiac conduction system disease. The goal of this study was to identify the incidence and predictors of permanent pacemaker implantation in patients hospitalized with Lyme disease. Methods A retrospective cohort analysis of the Nationwide Inpatient sample was performed to identify patients hospitalized with Lyme disease in the US between 2003 and 2014. Patients with Lyme carditis were defined as those hospitalized with Lyme disease who also had cardiac conduction disease, acute myocarditis, or acute pericarditis. Patients who already had pacemaker implants at the time of hospitalization (N = 310) were excluded from the Lyme carditis subgroup. The primary study outcome was permanent pacemaker implantation. Secondary outcomes included temporary cardiac pacing, permanent pacemaker implant, and in-hospital mortality. Results Of the 96,140 patients hospitalized with Lyme disease during the study period, 10,465 (11%) presented with Lyme carditis. Cardiac conduction system disease was present in 9,729 (93%) of patients with Lyme carditis. Permanent pacemaker implantation was performed in 1,033 patients (1% of all Lyme hospitalizations and 11% of patients with Lyme carditis-associated conduction system disease). Predictors of permanent pacemaker implantation included older age (OR: 1.06 per 1 year; 95% CI:1.05–1.07; P<0.001), complete heart block (OR: 21.5; 95% CI: 12.9–35.7; P<0.001), and sinoatrial node dysfunction (OR: 16.8; 95% CI: 8.7–32.6; P<0.001). In-hospital mortality rate was higher in patients with Lyme carditis (1.5%) than in patients without Lyme carditis (0.5%). Conclusions Approximately 11% of patients hospitalized with Lyme disease present with carditis, primarily in the form of cardiac conduction system disease. In this 12-year study, 1% of all hospitalized patients and 11% of those with Lyme-associated cardiac conduction system disease underwent permanent pacemaker implantation.


2021 ◽  
Vol 22 (21) ◽  
pp. 11368
Author(s):  
Xixia Peng ◽  
Gang Feng ◽  
Yanyong Zhang ◽  
Yuhua Sun

Cardiac development is a complex process that is strictly controlled by various factors, including PcG protein complexes. Several studies have reported the critical role of PRC2 in cardiogenesis. However, little is known about the regulation mechanism of PRC1 in embryonic heart development. To gain more insight into the mechanistic role of PRC1 in cardiogenesis, we generated a PRC1 loss-of-function zebrafish line by using the CRISPR/Cas9 system targeting rnf2, a gene encoding the core subunit shared by all PRC1 subfamilies. Our results revealed that Rnf2 is not involved in cardiomyocyte differentiation and heart tube formation, but that it is crucial to maintaining regular cardiac contraction. Further analysis suggested that Rnf2 loss-of-function disrupted cardiac sarcomere assembly through the ectopic activation of non-cardiac sarcomere genes in the developing heart. Meanwhile, Rnf2 deficiency disrupts the construction of the atrioventricular canal and the sinoatrial node by modulating the expression of bmp4 and other atrioventricular canal marker genes, leading to an impaired cardiac conduction system. The disorganized cardiac sarcomere and defective cardiac conduction system together contribute to defective cardiac contraction. Our results emphasize the critical role of PRC1 in the cardiac development.


2021 ◽  
Author(s):  
Iurii Karpenko ◽  
Dmytro Skoryi ◽  
Dmytro Volkov

Cardiac pacing is an established treatment option for patients with bradycardia and heart failure. In the recent decade, there is an increasing scientific and clinical interest in the topic of direct His bundle pacing (HBP) and left bundle branch pacing (LBBP) as options for cardiac conduction system pacing (CSP). The concept of CSP started evolving from the late 1970s, passing several historical landmarks. HBP and LBBP used in CSP proved to be successful in small cohorts of patients with various clinical conditions, including binodal disease, atrioventricular blocks, and in patients with bundle branch blocks with indications for cardiac resynchronization therapy. The scope of this chapter is synthesis and analysis of works devoted to this subject, as well as representation of the author’s experience in this topic. The chapter includes historical background, technical, anatomical, and clinical considerations of CSP, covers evidence base, discusses patient outcomes in line with the pros and cons of the abovementioned methods. The separate part describes practical aspects of different pacing modalities, including stages of the operation and pacemaker programming. The textual content of the chapter is accompanied by illustrations, ECGs, and intracardiac electrograms.


Sign in / Sign up

Export Citation Format

Share Document